Intensifying Treatment of Type 2 Diabetes Mellitus: Adding Insulin

Use of concentrated insulin human regular (U-500) for patients with diabetes

(2010) A. R. Segal et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

(2010) S. G. Swinnen et al.   DIABETES CARE

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study

(2010) S. Arnolds et al.   DIABETES CARE

Standards of Medical Care in Diabetes--2011

(2010)   DIABETES CARE

Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes

(2010) S. G. Swinnen et al.   DIABETES OBESITY & METABOLISM

Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus

(2009) C. D. Rochester et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine

(2009) Reinhard H A Becker et al.   CLINICAL PHARMACOKINETICS

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

(2009) R. A. DeFronzo   DIABETES

Insulin Therapy for Type 2 Diabetes

(2009) S. G. Swinnen et al.   DIABETES CARE

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETMstudy

(2009) L. Blonde et al.   DIABETES OBESITY & METABOLISM

Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study

(2009) M. Yenigun et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

(2009) S. Shah et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

(2008) Priscilla Hollander et al.   CLINICAL THERAPEUTICS

Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

(2008) J. C. Pickup et al.   DIABETES CARE

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study

(2008) A. B. King   DIABETES OBESITY & METABOLISM

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

(2008) A. Liebl et al.   DIABETES OBESITY & METABOLISM

Indirect Comparison of Once Daily Insulin Detemir and Glargine in Reducing Weight Gain and Hypoglycaemic Episodes when Administered in Addition to Conventional Oral Anti-Diabetic Therapy in Patients with Type-2 Diabetes

(2008) Walid Fakhoury et al.   PHARMACOLOGY

Initiating insulin in primary care—The role of modern premixed formulations

(2008) Robert Ligthelm et al.   Primary Care Diabetes